This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Renwu Jiang: Innovator in Antiviral Compounds
Introduction
Renwu Jiang is a notable inventor based in Dalian, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His innovative work has led to the creation of a unique compound that holds promise for treating viral diseases.
Latest Patents
Renwu Jiang holds a patent for a phillygenin glucuronic acid derivative, which is described as a general formula (I). This compound is characterized by various configurations of R groups, including R=H, R=CH, and others. The invention not only details the preparation method of this compound but also its application in pharmaceutical compositions aimed at combating antiviral diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Renwu Jiang has demonstrated a commitment to advancing medical science through his innovative research. His work has been recognized for its potential impact on the treatment of viral infections, showcasing his expertise in pharmaceutical chemistry.
Collaborations
Renwu Jiang has collaborated with notable colleagues, including Yu Zhang and Zhengxian Liu. Their combined efforts have contributed to the advancement of research in the field of antiviral compounds.
Conclusion
Renwu Jiang's contributions to the field of pharmaceuticals, particularly through his patented work on phillygenin glucuronic acid derivatives, highlight his role as an innovator in antiviral research. His ongoing efforts continue to pave the way for new therapeutic options in the fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile